Clinical Trials

200 enrolled 16 charts

HER2-positive Early Breast Cancer

NCT05415215 2026-02-10

ProHer

346 enrolled 20 charts

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT04700124 2026-02-05

KEYNOTE-B15

808 enrolled

Phase 3 Not yet recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT02448173 2026-02-02

A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

550 enrolled

Phase 1/2 Active not recruiting

Colonic Neoplasms

NCT06305767 2026-01-13

INTerpath-005

230 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT04770272 2026-01-12

neoMono

Phase 2 Terminated

442 enrolled 42 charts

Triple Negative Breast Neoplasms

NCT03567889 2025-12-17

NeoDREAM

Phase 3 Recruiting

186 enrolled

Dermatologic

Melanoma

NCT03924856 2025-08-28

KEYNOTE-866

907 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03924895 2025-08-28

KEYNOTE-905

595 enrolled 3 FDA

Urinary Bladder Neoplasms

NCT03725059 2025-07-11

KEYNOTE-756

1,240 enrolled

Breast Neoplasms

NCT03800134 2025-06-11

AEGEAN

825 enrolled 3 FDA

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT04109066 2025-01-08

CheckMate 7FL

521 enrolled 17 charts

Breast Neoplasms, Neoplasms

NCT06106568 2024-11-04

An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions

Completed

39,624 enrolled

Pancreatic Neoplasms

NCT02938299 2024-09-19

Pivotal

214 enrolled

Dermatologic

Melanoma

NCT03493854 2024-06-26

FeDeriCa

500 enrolled 28 charts 3 FDA

Breast Neoplasms

NCT03165994 2024-05-02

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

34 enrolled 18 charts

Phase NA Active not recruiting

Esophageal Neoplasms

NCT03012789 2024-04-30

NETest_Sx

40 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04629846 2024-04-19

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

517 enrolled

Breast Neoplasms

NCT03272477 2024-04-17

TP-II

257 enrolled

Breast Neoplasms

NCT02586025 2023-05-22

PEONY

329 enrolled 33 charts

Breast Neoplasms

NCT03916744 2023-03-10

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

75 enrolled 24 charts

Breast Neoplasms

NCT04436744 2023-02-02

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

221 enrolled 21 charts

Breast Neoplasms

NCT01265849 2022-08-19

IT-MATTERS

928 enrolled 25 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00840749 2020-07-14

STARS

Phase NA Terminated

36 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT03742401 2020-03-16

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

Phase NA Terminated

2 enrolled

Fibroadenoma

NCT00191126 2019-09-12

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC

263 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02301143 2019-03-20

LAPACT

107 enrolled 18 charts

Pancreatic Neoplasms

NCT01142778 2018-03-16

AVATAXHER

152 enrolled

Breast Neoplasms

NCT01444729 2017-10-26

Post Approval Commitment Study

Completed

305 enrolled

Dupuytren Contracture

NCT00865189 2017-08-04

INOVA

91 enrolled 16 charts

Rectal Neoplasms

NCT01213407 2016-05-19

GBM-Vax

87 enrolled

Brain Neoplasms, Glioblastoma, Glioma

NCT00704808 2015-09-09

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

Completed

180 enrolled 6 charts

Glioblastoma

NCT00024570 2014-11-14

Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma

Phase 1/2 Completed

60 enrolled

Astrocytoma, Glioblastoma, Glioma, Recurrence

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

101 enrolled 16 charts

Breast Neoplasms

NCT01637753 2012-07-11

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Phase NA Unknown

212 enrolled

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT01574729 2012-06-28

rAd-p53

Phase 2 Unknown

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00902083 2012-04-09

rAd-p53

Phase 4 Unknown

600 enrolled

Tumor-Agnostic

Neoplasms

NCT00902122 2012-04-09

rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

Phase 4 Unknown

600 enrolled

Head & Neck

Neoplasms, Thyroid Diseases

NCT00316134 2011-11-08

Multiple Biomarkers in Undiagnosed Pleural Effusion

Terminated

200 enrolled

Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Pleural Effusion, Malignant

NCT00191308 2011-10-21

Molecular Profiling in Lung Cancer Patients

30 enrolled 11 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00515086 2011-09-22

Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Phase 2 Terminated

41 enrolled 11 charts

Dyschromatosis symmetrica hereditaria 1, Glioblastoma

NCT00152217 2011-07-07

Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)

1,000 enrolled

Stomach Neoplasms

NCT00152230 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

900 enrolled

Colorectal Neoplasms

NCT00152243 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

500 enrolled

Stomach Neoplasms

NCT00089427 2011-07-04

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

24 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT00024557 2011-06-06

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

40 enrolled

Astrocytoma, Glioblastoma, Glioma, Recurrence

NCT00041587 2011-06-06

Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

Phase 1/2 Completed

80 enrolled

Astrocytoma, Glioblastoma, Glioma, Neoplasms

NCT00064779 2011-06-06

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

18 enrolled